Showing results (691-700 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|March 29, 2024
Comparative efficacy and safety of cabozantinib for malignant tumors: a systematic review and meta-analysisJingyang Su, Cui Ni, Yuqian Wu, et al.Expert Review of Anticancer Therapy|July 18, 2024
PROTACing the androgen receptor and other emerging therapeutics in prostate cancerPeter D Zang, Allen Seylani, Evan Y Yu, et al.Expert Review of Anticancer Therapy|July 6, 2024
Evaluating the efficacy and safety of trebananib in treating ovarian cancer and non-ovarian cancer patients: a meta-analysis and systematic reviewJialin Zhang, Jingyang Su, Yeyue Zhou, et al.Expert Review of Anticancer Therapy|July 1, 2024
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLCPierre Peterlin, Esma Saada-Bouzid, Mor Moskovitz, et al.Expert Review of Anticancer Therapy|April 10, 2024
Role of non-coding RNAs mediated pyroptosis on cancer therapy: a reviewDan Zhao, Tangwei Wu, Zheqiong Tan, et al.Expert Review of Anticancer Therapy|April 12, 2024
Targeting GPRC5D in multiple myelomaShatha Elemian, Samer Al HadidiExpert Review of Anticancer Therapy|September 5, 2024
Current immunotherapy techniques in meningiomaAlexandra J White, Maya Harary, Joshua Casaos, et al.Expert Review of Anticancer Therapy|September 3, 2024
Utilizing risk factors to guide treatment decisions in chronic lymphocytic leukemiaPaolo Lopedote, Adam S Kittai, Alexey DanilovExpert Review of Anticancer Therapy|August 29, 2024
PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probesTony Yu, Benjamin H LokExpert Review of Anticancer Therapy|October 5, 2024
Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directionsAram Bidikian, Jan P Bewersdorf, Rory M Shallis, et al.Pageof 310